阿里巴巴(BABA.US)盤前漲1.55% 新制造一號工程“犀牛智造”正式亮相
格隆匯9月16日丨阿里巴巴(BABA.US)盤前漲1.55%報282.27美元;港股市場阿里巴巴(9988.HK)今日收漲2.09%報273港元,折算成美股市場價格為281.73美元/ADS。阿里巴巴今日對外宣佈新產品“犀牛智造”,這是全球首個新制造平台,目前,“一號工程”犀牛智造工廠已在杭州正式投產。阿里稱,這一戰略級項目已在保密運行3年。作為阿里巴巴五新戰略中“新制造”的落地,犀牛智造的亮相是今年互聯網行業的最大創新。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.